specialized drugs

Iovance inventory drops 24% after it halts cancer-drug trial

Sanofi suffers main blow as its cutting-edge most cancers drug disappoints in Phase III trials

Kenvue’s inventory rises after favorable court docket ruling in Tylenol litigation

Medtronic will get FDA approval for brand spanking new heart-condition therapy

LifeMD’s inventory soars 13% as firm and Medifast to create weight-management program that features GLP-1 medication

Wuxi XDC Cayman shares surge in Hong Kong debut

WuXi XDC units its Hong Kong IPO value at excessive finish of vary

Novo Nordisk’s Wegovy cuts danger of coronary heart assault and stroke by 20% amongst folks with out diabetes, examine finds

AstraZeneca hikes earnings forecast as surging most cancers drug gross sales offset plunging income from COVID vaccines

Biogen and Eisai launch new Alzheimer’s drug knowledge which will help wider uptake